scholarly journals Is “Movember” an Effective Prostate Cancer Awareness Campaign Beyond the English Language? Insights From Google Trends Among Spanish Speakers

2021 ◽  
Vol 2 (6) ◽  
pp. 362-369
Author(s):  
Daniel A. González-Padilla ◽  
Rodrigo España-Navarro ◽  
José Daniel Subiela ◽  
Raj Kumar ◽  
Luis G. Medina ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Prostate Cancer ◽  
English Language ◽  
Spanish Language ◽  
Google Trends ◽  
Cáncer De Mama ◽  
Cancer Awareness ◽  
Awareness Campaign ◽  
Cáncer De Próstata ◽  
The Impact

Objective To evaluate the impact of the “Movember” awareness campaign (men’s health campaign that takes place every November) on internet search trends for information online about prostate cancer and to compare the results with those for “Pinktober” (the breast cancer awareness campaign that takes place in October) in the Spanish language as an indirect measure of its effectiveness. Methods Google Trends was used to evaluate the monthly relative search volumes (RSV) of the terms “cáncer de próstata” (prostate cancer), “cáncer de mama” (breast cancer), and “Movember” from January 2009 to December 2019 both in Spain and worldwide (in the Spanish language). Breast cancer was used as a comparator of the campaign impact. Mean increase in RSV on-campaign and off-campaign was calculated and compared using the Mann-Whitney U test and Joinpoint regression analysis to assess loss or gain of interest. Results The term “cáncer de próstata” showed a statistically significant increase during the campaign months both in Spain (17.4%; P < 0.001) and worldwide (35.4%; P < 0.001). Both “cáncer de próstata” and Movember showed a decreasing trend worldwide and in Spain, while “cáncer de mama” showed an increasing trend. Conclusion The Movember campaign generates a statistically significant increase in the search trends on “cancer de próstata” (prostate cancer) during the month of November (both in Spain and worldwide); when compared with the breast cancer campaign “Pinktober” these increases are of a lesser magnitude but still significant, suggesting that the campaign is effective beyond the English language, although the interest has been decreasing throughout the years.

Evaluating the impact of cancer awareness months in Mexico using internet search engine analytics.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e18056-e18056
Author(s):  
Jorge Humberto Hernandez-Felix ◽  
Mónica Isabel Meneses Medina ◽  
Edgar Omar Martos Armendariz ◽  
Mauricio Rivera Aguilar ◽  
Vanessa Rosas Camargo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Prostate Cancer ◽  
Colorectal Cancer ◽  
Media Analysis ◽  
Cáncer De Mama ◽  
Internet Search ◽  
Cancer Awareness ◽  
Awareness Campaigns ◽  
Search Volume ◽  
The Impact

e18056 Background: Cancer awareness months (CAM) are a health promotion tool that pursues to increase the public knowledge of a specific type of cancer. Awareness campaigns have benefited from the ease of access to the internet and social media. Analysis of internet search data has been used as an indirect tool to determine the information-seeking patterns of people and may reflect the impact of a campaign. We aim to determine national cancer awareness months’ impact on people’s internet search habits focusing on malignancies that have a specific awareness month in Mexico: breast, colorectal and prostate. Methods: We used Google Trends (GT) to obtain search volume indexes (SVIs), a term designed by GT scaled from 0 to 100 based on total searches during a specified period, of malignancies with an awareness month in Mexico from January 2008 to December 2018. Terms were consulted in Spanish: "cáncer de mama" (breast cancer), "cáncer de colon + cáncer colorrectal" (colon + colorectal cancer), "cáncer de próstata" (prostate cancer). We compared mean SVIs from each cancer awareness month to mean SVIs from the rest of the year using two-tailed two-independent sample T-tests. For prostate and colorectal, SVI’s were compared from the year its CAM was nationally instituted. Results: For breast cancer, mean SVI from October, its awareness month was 54.18 vs 12.09 for the rest of the year (p < 0.001). For colorectal cancer, mean SVI from its awareness month March, was 65.0 vs 55.5 for the rest of the year (p = 0.34). For prostate cancer, mean SVI from November, Mexican prostate awareness month, was 72.0 vs 35.52 for the rest of the year (p = 0.44). Conclusions: Google’s search volume for breast cancer was significantly higher in its awareness month compared to the rest of the year, which proves the impact of its CAM on modifying online activity. For more recently instituted CAMs on prostate and colorectal cancer, search volume didn’t change significantly between their CAM and the rest of the year. There are perhaps lessons to be learned from the breast cancer awareness month campaign which might usefully be adapted for the highest incident malignancies in Mexico.

Is Movember an effective prostate cancer awareness campaign in Spanish? Insights from Google trends

2021 ◽  
Vol 79 ◽  
pp. S1380-S1381
Author(s):  
D.A. González-Padilla ◽  
J.D. Subiela ◽  
R. España Navarro ◽  
J.M. De La Morena Gallego
Keyword(s):  
Prostate Cancer ◽  
Google Trends ◽  
Cancer Awareness ◽  
Awareness Campaign

scholarly journals Câncer de mama e próstata no Brasil: análise epidemiológica / Breast cancer and prostate in Brazil: epidemiological analysis

2021 ◽  
Vol 66 (1u) ◽  
pp. 1
Author(s):  
Lindcy Maticolli Cesar ◽  
Lucas Boa Sorte Faccin ◽  
Maiana Gueretta Martinez ◽  
Angélica Augusta Grigoli Dominato
Keyword(s):  
Breast Cancer ◽  
Prostate Cancer ◽  
Mortality Rate ◽  
Female Breast Cancer ◽  
Cáncer De Mama ◽  
Cáncer De Próstata ◽  
Age Related ◽  
Incidence And Mortality ◽  
Breast And Prostate Cancer ◽  
Epidemiological Profile

Introdução: O câncer está entre as principais doenças causadoras de morbimortalidade mundial relacionada com a idade, sendo mais comum entre pacientes com menos de 70 anos, e associado ao sexo com o câncer de mama feminino e de próstata para os homens. Objetivo: Traçar o perfil epidemiológicodos brasileiros acometidos pelo câncer próstata e de mama nas mulheres, comparar suas incidências e taxas de mortalidade nas macrorregiões do país. Metodologia: O estudo é descritivo do tipo ecológico com abordagem quantitativa dos dados da taxa de mortalidade, obtidos sobre o câncer de mama feminino e de próstata nas macrorregiões brasileiras, entre os anos de 2009 a 2018. Resultados: Os dados levantados mostraram que o total de óbitos entre mulheres nos anos do estudo foi de 5.315.155, sendo que 2,72% a foi causado pelo câncer de mama. Enquanto que, o número de óbitos entre os homens foi de 6.911.531, sendo 2,02% atribuídos ao câncer de próstata. Conclusão: Observou-se aumento da mortalidade de pacientes com câncer de mamae próstata no país ao longo do tempo do estudo, assim como aumento da taxa de mortalidade para ambos. Palavras chave: Câncer de mama, Câncer de próstata,Epidemiologia, Mortalidade, Incidência ABSTRACTIntroduction: Cancer is among the main diseases causing age-related morbidity and mortality worldwide, being more common among patients under 70 years, and associated with gender with breast cancer for women and prostatecancer for men. Objective: To trace the epidemiological profile of Brazilians affected by prostate and breast cancer in women, compare their incidence and mortality rates in the macro-regions of the country. Methodology: The study is descriptive of ecological type with quantitative approach of mortality rate data, obtained on female breast cancer and prostate cancer in Brazilian macro-regions, between the years 2009 to 2018. Results: The data surveyed showed that the total number of deaths among women in the years of the study was 5,315,155, 2.72% a was caused by breast cancer. Whereas, the number of deaths among men was 6,911,531, with 2.02% attributed to prostate cancer. Conclusion: We observed an increase in mortality of patients with breast and prostate cancer in the country over the time of the study, as well as an increase in the mortality rate for both.Keywords: Breast cancer, Prostate cancer, Epidemiology, Mortality, Incidence

scholarly journals Eficacia de la terapia de pareja con pacientes con cáncer: una revisión sistemática

2020 ◽  
Vol 17 (1) ◽  
pp. 73-89
Author(s):  
Noelia González Viniegra ◽  
Juan Antonio Cruzado
Keyword(s):  
Breast Cancer ◽  
Prostate Cancer ◽  
Clinical Trial ◽  
Sex Therapy ◽  
Cáncer De Mama ◽  
Cáncer De Próstata ◽  
Cancer Breast ◽  
Palabras Clave ◽  
Revisión Sistemática ◽  
Couple Sex Therapy

Objetivo: Conocer la eficacia o utilidad de la terapia de pareja en casos donde uno de los miembros de la pareja padece cáncer. Así como conocer en qué casos o en qué momentos puede ser más útil este tipo de terapia. Método: Se realizó una búsqueda sistemática en las bases de datos electrónicas: Scopus, Pubmed y PsycInfo, utilizándose palabras clave, tales como: Couple sex therapy, Cancer, Breast cancer, Prostate cancer, Couple psychological therapy, Intimacy, Clinical trial y Efficacy; y sus múltiples combinaciones. Se han incluido artículos en inglés de entre los años 2007 y 2019. Resultados: Los 11 estudios seleccionados únicamente trataban de cáncer de mama y próstata y la mayoría de ellos se lleva a cabo con una media relativamente pequeña. La mayoría de los tratamientos se aplica desde la corriente cognitivo-conductual y existen mejores resultados si el tratamiento está manualizado. En los casos de cáncer de próstata se trata con más normalidad aspectos relacionados con la sexualidad que en casos de cáncer de mama. Se observan mayores mejoras en cáncer de próstata ya que tienen que ver con aspectos sexuales además de psicológicos (pese a que con tiempo se pierdan dichas mejoras). Conclusiones: Se aprecia eficacia inicial en lo que a satisfacción de la relación y problemas sexuales en la pareja se refiere, pero estos resultados no se mantienen a lo largo del tiempo. Por lo que en general hablaríamos de una eficacia real baja.

scholarly journals Breast Cancer Awareness Month: The Impact of Even the Most Successful Campaigns Fades

2020 ◽  
Author(s):  
Frédéric Lapostolle ◽  
Lisa Weisslinger ◽  
Charles Durand ◽  
Frédéric Adnet
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Public Information ◽  
The United States ◽  
Google Trends ◽  
Cancer Awareness ◽  
Search Volume ◽  
Breast Cancer Awareness ◽  
Internet Searches ◽  
The Impact

Abstract BackgroundFor over 35 years the ‘Breast Cancer Awareness Month’ (BCAM) has worked to increase public information about breast cancer and to raise funds for research. The aim of this study was to analyze how the interest generated by this campaign evolved over time, in the US and other countries.MethodsWe investigated the Google Trends® according to previously recommended methods. The study was based on Internet searches using the term ‘’breast cancer’’ worldwide and in the United-States. Google Trends® gives the relative search volume of every request as an index on a scale from 0 to 100, (100 corresponding to the maximum number of requests during the studied period). We compared the relative searches index using the term ‘’breast cancer’’ during October, the breast cancer awareness month, and the rest of the of the year avec a 10 years period.Results120 months were analyzed including 10 October months. Median index for worldwide searches on ‘’breast cancer’’ during the 110 months was 35 (34-39). It didn’t significantly change during the study period (R2=0,3). Median index of the 10 peaks was 83 (64-92) (p<0,001 vs 110 months). The peak index linearly decreased (R2=0,88) during the study period. It reached 100 in 2012 and 64 in 2020. In the United-States, median index for searches during the 110 months was 28 (26-32). It didn’t significantly change during the study period (R2=0,3). Median index of the 10 peaks was 83 (63-92) (p<0,001 vs 110 months). The peak index linearly decreased (R2=0,73) during the study period. It reached 100 in 2012 and 64 in 2020.ConclusionsThis internet activity study shows that the impact of the ‘Breast Cancer Awareness Month’ seems to be slowly decreasing. The number of Internet searches generated by the campaign has been reduced by almost 40% in both the United-States and worldwide.

The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs

2006 ◽  
Vol 101 (1) ◽  
pp. 95-104 ◽  
Author(s):  
Peter A. Fasching ◽  
Gunter von Minckwitz ◽  
Thorsten Fischer ◽  
Manfred Kaufmann ◽  
Beate Schultz-Zehden ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Socioeconomic Status ◽  
Cancer Prevention ◽  
Breast Cancer Prevention ◽  
Cancer Awareness ◽  
Breast Cancer Awareness ◽  
The Impact ◽  
To Receive

‘Be Clear on Cancer’: the impact of the UK National Bowel Cancer Awareness Campaign

2013 ◽  
Vol 15 (8) ◽  
pp. 963-967 ◽  
Author(s):  
O. Peacock ◽  
S. Clayton ◽  
F. Atkinson ◽  
G. M. Tierney ◽  
J. N. Lund
Keyword(s):  
Bowel Cancer ◽  
Cancer Awareness ◽  
Awareness Campaign ◽  
The Uk ◽  
The Impact

Nilutamide: An Antiandrogen for the Treatment of Prostate Cancer

1997 ◽  
Vol 31 (1) ◽  
pp. 65-75 ◽  
Author(s):  
Ernest J Dole ◽  
Mark T Holdsworth
Keyword(s):  
Prostate Cancer ◽  
Adverse Effects ◽  
Advanced Prostate Cancer ◽  
English Language ◽  
Data Extraction ◽  
Performance Status ◽  
Major Advance ◽  
Improved Performance ◽  
The Impact ◽  
Nonsteroidal Antiandrogens

OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy, and adverse effects of nilutamide and to compare this agent with the currently marketed nonsteroidal antiandrogens (i.e., bicalutamide, flutamide) by critically analyzing the published literature. DATA SOURCES: MEDLINE (1980–1995) and CANCERLIT (1991–1995) were searched for English-language publications using the terms nilutamide, bicalutamide, and flutamide alone, and either nilutamide or androgen antagonists in combination with prostatic neoplasms. STUDY SELECTION AND DATA EXTRACTION: All articles with subject matter on nilutamide, bicalutamide, and flutamide were considered for inclusion. For studies published in more than one journal, the first publication was used unless a subsequent publication included additional or follow-up data, in which case the latter publication was cited instead. DATA SYNTHESIS: Nilutamide was effective in combination with orchiectomy in improving responses in patients with advanced prostate cancer. However, patient survival was not improved in these trials, and improvements in bone pain did not usually result in improved performance status in these patients. The few trials of nilutamide monotherapy or nilutamide in combination with a luteinizing hormone-releasing hormone analog are too small to draw meaningful conclusions regarding its efficacy or its role in the treatment of advanced prostate cancer. No comparative trials of nilutamide with other antiandrogens and no analysis of the impact of nilutamide on patient quality of life are currently available. Nilutamide appears to produce a higher frequency of adverse effects than the other currently marketed nonsteroidal antiandrogens, bicalutamide and flutamide. CONCLUSIONS: Nilutamide does not appear to represent a major advance in the treatment of advanced prostate cancer and appears to be somewhat inferior to both flutamide and bicalutamide with regard to adverse effects. Nilutamide should not be considered the antiandrogen of choice in the treatment of advanced prostate cancer.

Sign in / Sign up

Export Citation Format

Share Document